Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: HyperHep B
Active Ingredient: Hepatitis B immunoglobulin, human 220IU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: EastMed Pharmacy Limited t/a EastMed Logistics
Manufacturer: Talecris Biotherapeutics, Inc., Clayton, North Carolina, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 6th day of May 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).